Atlas Trials

Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study.

Clinical trial NCT05553873 · RECRUITING

Trial details

NCT number
NCT05553873
Sponsor
University of Milano Bicocca
Status
RECRUITING
Study type
OBSERVATIONAL
Myeloproliferative DiseaseInflammatory Markers
Start date
2022-09-08
Primary completion
2026-12-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.